 |
|
VIGNETTES
Leukocytoclastic Vasculitis Masquerading as Hand-Foot Syndrome in a Patient Treated With Sorafenib
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Report of a Case
A 70-year-old white man with metastatic non–small cell lung carcinoma developed discrete, painful, erythematous small plaques and bullae with dusky to violaceous centers on his fingertips approximately 25 days after starting treatment with oral sorafenib (BAY 43-9006), 400 mg twice daily. Several days later, similar targetlike lesions appeared on his palms, elbows, and the dorsal surface of his hands (Figure 1). In addition, large bullae developed on the soles of his feet. A skin biopsy specimen revealed fibrinoid necrosis of the walls of superficial dermal capillaries with surrounding leukocytolysis, dermal hemorrhage, and necrosis of the overlying epidermis, findings consistent with leukocytoclastic vasculitis (LCV) (Figure 2). Results of staining for bacteria, acid-fast bacilli, and fungi were negative. Findings of a workup for possible endocarditis, including transesophageal echocardiography and blood cultures, were negative. Assay results for antinuclear antibody, cytoplasmic antineutrophil cytoplasmic antibody, perinuclear antineutrophil cytoplasmic antibody, and cryoglobulins . . . [Full Text of this Article]
Comment
AUTHOR INFORMATION
Nancy M. Chung, MD;
Martin Gutierrez, MD;
Maria L. Turner, MD
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
Azad et al.
Clin. Cancer Res. 2009;15:1411-1416.
ABSTRACT
| FULL TEXT
|
